Journal of Molecular and Cellular Cardiology
Volume 46, Issue 3 , Pages 352-359 , March 2009

Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes

  • Anna Grazia Recchia

      Affiliations

    • Department of Pharmaco-Biology, Cell Biology, University of Calabria, 87036 Rende (CS), Italy
    • ,
  • Elisabetta Filice

      Affiliations

    • Department of Pharmaco-Biology, Cell Biology, University of Calabria, 87036 Rende (CS), Italy
    • ,
  • Daniela Pellegrino

      Affiliations

    • Department of Pharmaco-Biology, Cell Biology, University of Calabria, 87036 Rende (CS), Italy
    • ,
  • Aldo Dobrina

      Affiliations

    • Department of Physiology and Pathology, University of Trieste, Italy
    • ,
  • Maria Carmela Cerra

      Affiliations

    • Department of Pharmaco-Biology, Cell Biology, University of Calabria, 87036 Rende (CS), Italy
    • ,
  • Marcello Maggiolini

      Affiliations

    • Department of Pharmaco-Biology, Cell Biology, University of Calabria, 87036 Rende (CS), Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 0984 493076; fax: +39 0984 493458.

Received 30 July 2008 ,Revised 24 November 2008 ,Accepted 29 November 2008.

References 

  1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide producing vascular endothelial cells. Nature. 1988;332:411–415
  2. Masaki T. Historical review: endothelin. Trends Pharmacol. Sci. 2004;25:219–224
  3. Kirkby NS, Hadoke PW, Bagnall AJ, Webb DJ. The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?. Br. J. Pharmacol. 2008;153:1105–1119
  4. Motte S, McEntee K, Naeije R. Endothelin receptor antagonists. Pharmacol. Ther. 2006;110:386–414
  5. Izumi Y, Kim S, Zhan Y, Namba M, Yasumoto H, Iwao H. Important role of angiotensin II-mediated c-Jun NH(2)-terminal kinase activation in cardiac hypertrophy in hypertensive rats. Hypertension. 2000;36:511–516
  6. Yano M, Kim S, Izumi Y, Yamanaka S, Iwao H. Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension. Circ. Res. 1998;83:752–760
  7. Brown PH, Chen TK, Birrer MJ. Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene. 1994;9:791–799
  8. Leask A, Abraham DJ. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J. Cell Sci. 2006;119:4803–4810
  9. Shi-Wen X, Leask A, Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 2008;19:133–144
  10. Perbal B. CCN proteins: multifunctional signaling regulators. Lancet. 2004;363:62–64
  11. Hayata N, Fujio Y, Yamamoto Y, Iwakura T, Obana M, Takai M, et al. Connective tissue growth factor induces cardiac hypertrophy through Akt signaling. Biochem. Biophys. Res. Commun. 2008;370:274–278
  12. Yokoi H, Mukoyama M, Nagae T, Mori K, Suganami T, Sawai K, et al. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 2004;15:1430–1440
  13. Li G, Xie Q, Shi Y, Li D, Zhang M, Jiang S, et al. Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. J. Gene Med. 2006;8:889–900
  14. Kemp TJ, Aggeli IK, Sugden PH, Clerk A. Phenylephrine and endothelin-1 upregulate connective tissue growth factor in neonatal rat cardiac myocytes. J. Mol. Cell. Cardiol. 2004;37:603–606
  15. Ruperez M, Lorenzo O, Blanco-Colio LM, Esteban V, Egido J, Ruiz-Ortega M. Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation. 2003;108:1499–1505
  16. Rodriguez-Vita J, Ruiz-Ortega M, Rupérez M, Esteban V, Sanchez-López E, Plaza JJ, et al. Endothelin-1, via ETA receptor and independently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells. Circ. Res. 2005;97:125–134
  17. Mori T, Kawara S, Shinozakai M, Hayashi N, Kakinuma T, Igarashi A, et al. Role and interaction of connective tissue growth factor with transforming growth factor beta in persistent fibrosis: a mouse model of fibrosis. J. Cell. Physiol. 1999;181:153–159
  18. Fernandez-Patron C. Therapeutic potential of the epidermal growth factor receptor transactivation in hypertension: a convergent signaling pathway of vascular tone, oxidative stress, and hypertrophic growth downstream of vasoactive G-protein-coupled receptors?. Can. J. Physiol. Pharmacol. 2007;85:97–104
  19. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. U. S. A. 1998;95:2979–2984
  20. Cerra MC, De Iuri L, Angelone T, Corti A, Tota B. Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart. Basic Res. Cardiol. 2006;101:43–52
  21. Javadov SA, Lim KH, Kerr PM, Suleiman MS, Angelici GD, Halestrap AP. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc. Res. 2000;45:360–369
  22. Chaqour B, Yang R, Sha Q. Mechanical stretch modulates the promoter activity of the profibrotic factor CCN2 through increased actin polymerization and NF-kappaB activation. J. Biol. Chem. 2006;281:20608–20622
  23. Vinciguerra M, Vivacqua A, Fasanella G, Gallo A, Cuozzo C, Morano A, et al. Differential phosphorylation of c-Jun and JunD in response to the epidermal growth factor is determined by the structure of MAPK targeting sequences. J. Biol. Chem. 2004;279:9634–9641
  24. Olive M, Krylov D, Echlin DR, Gardner K, Taparowsky E, Vinson C. A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis. J. Biol. Chem. 1997;272:18586–18594
  25. Chansel D, Ciroldi M, Vandermeersch S, Jackson LF, Gomez AM, Henrion D, et al. Heparin binding EGF is necessary for vasospastic response to endothelin. FASEB J. 2006;20:1936–1938
  26. Zwick E, Hackel PO, Prenzel N, Ullrich A. The EGF receptor as central transducer of heterologous signaling systems. Trends Pharmacol. Sci. 1999;10:408–412
  27. Carpenter G. EGF receptor transactivation mediated by the proteolytic production of EGF-like agonists. Sci. STKE. 2000;15 PEI
  28. Chen CH, Cheng TH, Lin H, Shih NL, Chen YL, Chen YS, et al. Reactive oxygen species generation is involved in epidermal growth factor receptor transactivation through the transient oxidization of Src homology 2-containing tyrosine phosphatase in endothelin-1 signaling pathway in rat cardiac fibroblasts. Mol. Pharmacol. 2006;69:1347–1355
  29. Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signaling by G-protein-coupled receptors. Nature. 1996;379:557–560
  30. Joo CK, Kim HS, Park JY, Seomun Y, Son MJ, Kim JT. Ligand release-independent transactivation of epidermal growth factor receptor by transforming growth factor-beta involves multiple signaling pathways. Oncogene. 2008;27:614–628
  31. Kodama H, Fukuda K, Takahashi E, Tahara S, Tomita Y, Ieda M, et al. Selective involvement of p130Cas/Crk/Pyk2/c-Src in endothelin-1-induced JNK activation. Hypertension. 2003;41:1372–1379
  32. Kodama H, Fukuda K, Takahashi T, Sano M, Kato T, Tahara S, et al. Role of EGF Receptor and Pyk2 in endothelin-1-induced ERK activation in rat cardiomyocytes. Mol. Cell. Cardiol. 2002;34(2):139–150
  33. Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, et al. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17-β-estradiol and phytoestrogens in breast cancer cells. J. Biol. Chem. 2004;279:27008–27016
  34. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, et al. G-protein coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17-β-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 2007;67:1859–1866
  35. Xia W, Kong W, Wang Z, Phan TT, Lim IJ, Longaker MT, et al. Increased CCN2 transcription in keloid fibroblasts requires cooperativity between AP-1 and SMAD binding sites. Ann. Surg. 2007;246:886–895
  36. Moritani NH, Kubota S, Eguchi T, Fukunaga T, Yamashiro T, Takano-Yamamoto T, et al. Interaction of AP-1 and the ctgf gene: a possible driver of chondrocyte hypertrophy in growth cartilage. J. Bone Miner. Metab. 2003;21:205–210
  37. Sugden PH, Clerk A. Endothelin signaling in the cardiac myocyte and its pathophysiological relevance. Curr. Vasc. Pharmacol. 2005;3:343–351
  38. He F, Zhang Q, Kuruba R, Gao X, Li J, Li Y, et al. Upregulation of decorin by FXR in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 2008;372:746–751
  39. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat. Rev., Mol. Cell Biol. 2006;7:589–600
  40. Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH. CTGF expression is induces by TGF-β in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J. Mol. Cell. Cardiol. 2000;32:1805–1819
  41. Finckenberg P, Inkinen K, Ahonen J, Merasto S, Louhelainen M, Vapaatalo H, et al. Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am. J. Pathol. 2003;163:355–366
  42. Way KJ, Isshiki K, Suzuma K, Yokota T, Zvagelsky D, Schoen FJ, et al. Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C β2 activation and diabetes. Diabetes. 2002;51:2709–2718
  43. Ohnishi H, Oka T, Kusachi S, Nakanishi T, Takeda K, Nakahama M, et al. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J. Mol. Cell. Cardiol. 1998;30:2411–2422
  44. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature. 1992;360:361–364
  45. Kolb M, Margetts PJ, Galt T, Sime PJ, Xing Z, Schmidt M, et al. Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am. J. Respir. Crit. Care Med. 2001;163:770–777
  46. Kolb M, Margetts PJ, Sime PJ, Gauldie J. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am. J. Physiol. Lung Cell Mol. Physiol. 2001;280:L1327–L1334
  47. Al Haj Zen A, Caligiuri G, Sainz J, Lemitre M, Demerens C, Lafont A. Decorin overexpression reduces atherosclerosis development in apolipoprotein E-deficient mice. Atherosclerosis. 2006;187:31–39
  48. Guarda E, Katwa LC, Myers PR, Tyagi SC, Weber KT. Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res. 1993;27:2130–2134
  49. Best PJ, McKenna CJ, Hasdai D, Holmes DR, Lerman A. Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia. Circulation. 1999;99:1747–1752
  50. Fukuda G, Khan ZA, Barbin YP, Farhangkhoee H, Tilton RG, Chakrabarti S. Endothelin-mediated remodeling in aortas of diabetic rats. Diabetes Metab. Res. Rev. 2004;21:367–375
  51. Schinelli S, Zanassi P, Paolillo M, Wang H, Feliciello A, Gallo V. Stimulation of endothelin B receptors in astrocytes induces cAMP response element-binding protein phosphorylation and c-fos expression via multiple mitogen-activated protein kinase signaling pathways. J. Neurosci. 2001;21:8842–8853
  52. Gadea A, Schinelli S, Gallo V. Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway. J. Neurosci. 2008;10:2394–2408
  53. Rauh A, Windischhofer W, Kovacevic A, DeVaney T, Huber E, Semlitsch M, et al. Endothelin (ET)-1 and ET-3 promote expression of c-fos and c-jun in human choriocarcinoma via ET(B) receptor-mediated G(i)- and G(q)-pathways and MAP kinase activation. Br. J. Pharmacol. 2008;154:13–24
  54. Omura T, Yoshiyama M, Yoshida K, Nakamura Y, Kim S, Iwao H, et al. Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrine. Hypertension. 2002;39:81–86

PII: S0022-2828(08)01437-5

doi: 10.1016/j.yjmcc.2008.11.017

Journal of Molecular and Cellular Cardiology
Volume 46, Issue 3 , Pages 352-359 , March 2009

Article Tools

* Image Usage & Resolution